Approval · Notice of Compliance 18612 · 2016
PAZEO: Notice of Compliance 18612
Issued October 28, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18612
- Date
- October 28, 2016
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PAZEO | 02458551 | Marketed |
Medicinal ingredients
- OLOPATADINE HCL 0.7 PER